Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2027
Published on: 2024-11-24 | No of Pages : 320 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2027
The global plant based biomanufacturing market is projected to accomplish extraordinary growth in the forecast period, 2023-2027, with an impressive CAGR. The market growth can be attributed to the advancing healthcare capabilities to device treatment from plant based elements. Moreover, the increasing number of pipeline products that are a part of plant based biologics is further driving the growth of the global plant based biomanufacturing market in the upcoming five years. Also, with rising demands for human biologics and to make these procedures affordable and less time-consuming, the global plant based biomanufacturing market is expected to grow substantially in the next five years. Additionally, recent developments in plant expression vectors, downstream processing, and glycoengineering have established plants as a superior alternative to biologics production. As the next best commercial development in the field of biotechnology, the global plant based biomanufacturing market is anticipated to register esteemed growth in the future five years.
Plant based biomanufacturing includes protein manufacturing processes through recombinant protein production. These proteins include protein biopolymers, industrial proteins and enzymes, and therapeutic proteins. The production processes involve a narrowing diversity of bioreactors for cell, hairy root, microalgae, and moss cultivation. Direct use of cultivated plant cells, whole or minimally processed plants, or plant parts (e.g., seeds, dried leaves) is in development for industrial/bioenergy applications as well as for therapeutics and vaccines and plays a vital role in bio-pharmaceutical productions.
The global plant based biomanufacturing is segmented by product type, technology, source, end-user, competitional landscape, and regional distribution. Based on product type, the market is further bifurcated into antibodies, vaccines, proteins, biologics, enzymes, and others. Biologics are anticipated to hold the largest revenue shares of the market and dominate the segment in the next five years on account of changing consumer preferences to more nutritional and herbal products. Consistent research and advancing plant based medicinal nutrient is also driving the growth of the global plant based biomanufacturing market in the upcoming five years. Vaccines are expected to show the fastest growing CAGR in the next five years on account of rapidly evolving drug development procedures that have plant based recombinant proteins. Also, the recent pandemic situation due to COVID-19 has enhanced the healthcare industry's inclination toward finding plant based vaccines for the protection against deadly viruses. These factors are actively influencing the growth of the global plant based biomanufacturing market in the future five years of the forecast until 2027.
Holding the major shares of the global plant based biomanufacturing market are Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle), Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet Biotechnology Inc., Zea Biosciences Corp., among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through plant based biomanufacturing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfy the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Objective of the Study
- To analyze the historical growth of the market size of global plant based biomanufacturing market from 2017 to 2020.
- To estimate and forecast the market size of global plant based biomanufacturing market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast global plant based biomanufacturing market based on product type, technology, source, end user, competitional landscape, and regional distribution.
- To identify dominant region or segment in the global plant based biomanufacturing market.
- To identify drivers and challenges for global plant based biomanufacturing market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global plant based biomanufacturing market.
- To identify and analyze the profile of leading players operating in global plant based biomanufacturing market.
- To identify key sustainable strategies adopted by market players in global plant based biomanufacturing market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufactures which could not be identified due to the limitations of secondary research. Market insights research analyzed the manufactures, distribution channels and presence of all major players across the country.
Market insights research calculated the market size of global plant based biomanufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Market insights research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by Market insights research.
Key Target Audience
- Manufacturers, end users, and other stakeholders
- Distributers and suppliers of products and other stakeholders
- Organizations, forums, and alliances related to plant based biomanufacturing
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Product Type · Technology · Source · End User |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia |
Key companies profiled | Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle), Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet Biotechnology Inc., Zea Biosciences Corp. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |